KYNB
Kyntra Bio
KYNB
KYNB
33 hedge funds and large institutions have $10.1M invested in Kyntra Bio in 2025 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
11% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 9
27% less capital invested
Capital invested by funds: $13.9M → $10.1M (-$3.77M)
Holders
33
Holding in Top 10
–
Calls
$2.11M
Puts
$422K
Top Buyers
| 1 | +$223K | |
| 2 | +$215K | |
| 3 | +$205K | |
| 4 |
DS
DRW Securities
Chicago,
Illinois
|
+$188K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$126K |
Top Sellers
| 1 | -$721K | |
| 2 | -$390K | |
| 3 | -$66.1K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$45.9K |
| 5 |
Squarepoint
New York
|
-$40.9K |
